Results 201 to 210 of about 166,379,765 (297)

Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study. [PDF]

J Health Econ Outcomes Res
Karami H, Rafati S, Shirvani Shiri M, Mouseli A, Salari H, Ghanbarnejad A, Nowrouzpour M, Noroozian F, Alizadeh A, Asadi F, Salehi N.   +10 more
europepmc   +1 more source

Drug costs; unemployment; illness in the Falklands [PDF]

BMJ, 1982
openaire   +2 more sources

The Role of Glutamatergic and Dopaminergic Genes in Resistant Schizophrenia: A Systematic Review

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Psychosis is a heterogeneous disorder, with approximately one‐third of patients experiencing treatment resistance, predominantly among individuals diagnosed with Schizophrenia. Treatment‐resistant schizophrenia (TRS) may stem from a distinct biological signature, involving abnormalities in the dopaminergic and glutamatergic systems.
Maria Teresa Moreno‐Calle, Silvia Iñiguez‐Barrio, Maria Aurora Arrue, Leire Erkoreka   +3 more
wiley   +1 more source

Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness Study. [PDF]

Drugs Real World Outcomes
Paoletti M, Vizza D, D'Alto M, Ghio S, Scelsi L, Badagliacca R, Argiento P, Raineri C, Sciattella P.   +8 more
europepmc   +1 more source

The Diagnosis That Arrived Decades Late: Living Without and Then With Myhre Syndrome

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome (MIM #139210) is a rare multisystem disorder first described in 1981, characterized by short stature, neurodevelopmental delay, joint contractures, and cardiopulmonary complications. Its molecular basis, recurrent pathogenic variants in SMAD4, was not discovered until 2011. This narrative is based on a review of medical records,
Abdallah F. Elias
wiley   +1 more source

The economic burden of loiasis: A comprehensive cost-of-illness analysis of regionally representative, individual-level data from rural Gabon. [PDF]

PLoS One
Mbavu CI, Perlik K, Stargardt T, Todagbe Agnandji S, Adegnika OS, Zoleko-Manego R, Ramharter M, Priebe J.   +7 more
europepmc   +1 more source

The International Consortium for Arthrogryposis: A Collaborative Framework for Early Detection, Care, Research, and Education

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Arthrogryposis multiplex congenita (AMC) is a group of rare congenital conditions, characterized by multiple joint contractures but may involve any body system including central nervous system. AMC is etiologically heterogeneous, with over 400 genetic and many non‐genetic causes implicated in its prenatal development.
Shahrzad Nematollahi, Noa Bouzaglo, Victoria Castillo Sanchez, Johanna I. P. de‐Vries, Klaus Dieterich, Alicja Fafara, Isabel Filges, Philip Giampietro, Göknur Haliloğlu, Judith Hall, Coleman Hilton, Remco Jansen, Valentina Maestri, Carolina Navalon, Daniel Natera de Benito, Tony Pan, Ani Samargian, Bonita Sawatzky, Harold van Bosse, Paul A. Trainor, Noémi Dahan‐Oliel   +20 more
wiley   +1 more source

Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis. [PDF]

J Health Econ Outcomes Res
Alenzi K, Alturaiki A, Fatani M, Alsogair S, Saeed AM, Behiry A, Almomatin A.   +6 more
europepmc   +1 more source

The Legislation for Providing Animal Access in Australian Residential Aged Care: It's Not a Zoo

Australian Journal of Social Issues, EarlyView.
ABSTRACT Providing meaningful animal contact to residential aged care facility (RACF) residents is problematic due to a lack of animal policies and National Guidelines. This paper examines how Australian Legislation could influence access to animal contact in RACFs and aims to answer the question, ‘Could current Legislation facilitate the development ...
Wendy Newton, Tania Signal, Jenni A. Judd   +2 more
wiley   +1 more source

Direct and indirect costs associated with declining distance visual acuity: A nationwide longitudinal cost-of-illness study with 11-year follow-up. [PDF]

Acta Ophthalmol
Taipale J, Purola P, Nättinen J, Väätäinen S, Koskinen S, Uusitalo H.   +5 more
europepmc   +1 more source